Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1991-2-28
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0369-8114
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
808-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2274365-Antineoplastic Agents,
pubmed-meshheading:2274365-Cisplatin,
pubmed-meshheading:2274365-Combined Modality Therapy,
pubmed-meshheading:2274365-Cystectomy,
pubmed-meshheading:2274365-Humans,
pubmed-meshheading:2274365-Prognosis,
pubmed-meshheading:2274365-Urinary Bladder Neoplasms
|
pubmed:year |
1990
|
pubmed:articleTitle |
[New therapeutic modalities in invasive bladder tumors].
|
pubmed:affiliation |
Clinique Sainte-Catherine, Avignon, France.
|
pubmed:publicationType |
Journal Article
|